<?xml version="1.0" encoding="UTF-8"?>
<Pathway xmlns="http://pathvisio.org/GPML/2013a" Name="Degradation pathway of sphingolipids, including diseases" Version="20161102" Organism="Homo sapiens">
  <Comment Source="WikiPathways-description">The degradation of SphingoLipids (SLs) occurs through a series of specific hydrolases in the lysosome, after the compounds have been transported via the endosomal pathway. Disorders resulting from an enzyme defect are highlighted in pink. Hydrolase defects result in accumulation and lysosomal storage of substrates, leading to cell pathology.
This pathway was inspired by Chapter 25 ("Lysosomal Storage Disorders Including Neuronal Ceroid Lipofuscinoses") of the book of Blau (ISBN 3642403360 (978-3642403361)).

Proteins on this pathway have targeted assays available via the [https://assays.cancer.gov/available_assays?wp_id=WP4153 CPTAC Assay Portal]</Comment>
  <Comment Source="WikiPathways-description">New Pathway on Sphingolipids.</Comment>
  <Comment Source="WikiPathways-description">Test pathway to include dieases in pathways, in order to deduce biomarkers.</Comment>
  <BiopaxRef>eee</BiopaxRef>
  <Graphics BoardWidth="1355.47971834022" BoardHeight="1006.1323853425366"/>
  <DataNode TextLabel="HEXB" GraphId="a51f2" Type="Protein" GroupRef="fa305">
        </DataNode>
  <DataNode TextLabel="digalactosylceramide" GraphId="a5d49" Type="Metabolite" GroupRef="de500">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="GM1-beta-galactosidase (GLB)" GraphId="a6abc" Type="Protein" GroupRef="b1bab">
        </DataNode>
  <DataNode TextLabel="Sap-B" GraphId="a9922" Type="Protein" GroupRef="b1bab">
    <Comment>SaposinB</Comment>
        </DataNode>
  <DataNode TextLabel="digalactosylceramide beta" GraphId="afe5d" Type="Metabolite" GroupRef="de500">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="HEXA" GraphId="b205a" Type="Protein" GroupRef="ec2eb">
    <Comment>Hexosaminidase A; HEXA and the cofactor GM2 activator protein catalyze the degradation of the GM2 gangliosides</Comment>
    <BiopaxRef>bd5</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Globoside" GraphId="b2c82" Type="Metabolite" GroupRef="cbadc">
    <Comment/>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="sialidase 2" GraphId="b42d9" Type="Protein" GroupRef="ff6aa">
        </DataNode>
  <DataNode TextLabel="GLB1" GraphId="b81b1" Type="GeneProduct" GroupRef="b1bab">
    <Comment>GM1-beta-galactosidase 1</Comment>
        </DataNode>
  <DataNode TextLabel="acrylsulfatase A" GraphId="bbb06" Type="Protein" GroupRef="cffd8">
    <Comment>Arylsulfatase A (or cerebroside-sulfatase)</Comment>
        </DataNode>
  <DataNode TextLabel="sialidase 1" GraphId="bbf5a" Type="Protein" GroupRef="ff6aa">
        </DataNode>
  <DataNode TextLabel="Globoside example 1" GraphId="c221a" Type="Metabolite" GroupRef="cbadc">
    <Comment>N-acetyl-beta-D-galactosaminyl-(1-&gt;3)-alpha-D-galactosyl-(1-&gt;4)-beta-D-galactosyl-(1-&gt;4)-beta-D-glucosyl-(1-&gt;1')-ceramide</Comment>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="sphingomyelinase" GraphId="c480e" Type="Protein">
    <Comment>Sphingomyelin phosphodiesterase (also known as neutral sphingomyelinase, sphingomyelinase, or SMase)</Comment>
        </DataNode>
  <DataNode TextLabel="sialidase" GraphId="c8be0" Type="Protein" GroupRef="ff6aa">
        </DataNode>
  <DataNode TextLabel="globotriaosylceramide" GraphId="ca46d" Type="Metabolite">
    <Comment>also known as CD77, Gb3, and ceramide trihexoside</Comment>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="glucosylceramide-beta-glucosidase" GraphId="d054b" Type="Protein" GroupRef="ca76d">
        </DataNode>
  <DataNode TextLabel="GM2A " GraphId="d64b5" Type="Protein" GroupRef="ec2eb">
    <Comment/>
        </DataNode>
  <DataNode TextLabel="beta-hexosaminidase A, B" GraphId="dc40c" Type="Protein" GroupRef="fa305">
        </DataNode>
  <DataNode TextLabel="Globoside example 2" GraphId="df235" Type="Metabolite" GroupRef="cbadc">
    <Comment>N-acetyl-beta-D-galactosaminyl-(1-&gt;3)-alpha-D-galactosyl-(1-&gt;4)-beta-D-galactosyl-(1-&gt;4)-beta-D-glucosyl-(1-&gt;1')-N-acylsphing-4-enine</Comment>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="alpha-galactosidase A" GraphId="e23ba" Type="Protein" GroupRef="f615c">
        </DataNode>
  <DataNode TextLabel="sialidase 3" GraphId="e3554" Type="Protein" GroupRef="ff6aa">
        </DataNode>
  <DataNode TextLabel="alpha-galactosidase A" GraphId="e3eef" Type="Protein" GroupRef="dae5a">
        </DataNode>
  <DataNode TextLabel="acid ceramidase" GraphId="e83ac" Type="Protein" GroupRef="eca86">
    <Comment>Acid ceramidase (N-acylsphingosine deacylase, ASAH1)</Comment>
        </DataNode>
  <DataNode TextLabel="digalactosylceramide alpha" GraphId="e8e88" Type="Metabolite" GroupRef="de500">
    <Comment>alpha-D-galactosyl-(1-&gt;4)-beta-D-galactosyl-N-(pentacosanoyl)sphingosine</Comment>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="GalCer-beta-galactosidase" GraphId="eb907" Type="Protein" GroupRef="f5915">
    <Comment>GALCERase</Comment>
        </DataNode>
  <DataNode TextLabel="sialidase 4" GraphId="f91e6" Type="Protein" GroupRef="ff6aa">
        </DataNode>
  <DataNode TextLabel="HEXA" GraphId="fd43d" Type="Protein" GroupRef="fa305">
        </DataNode>
  <DataNode TextLabel="GA2" GraphId="a2bb3" Type="Metabolite">
    <Comment>ganglioside GA2</Comment>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="GM3" GraphId="fd574" Type="Metabolite">
    <Comment>ganglioside GM3</Comment>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Ceramide" GraphId="e1855" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Sphingosine" GraphId="f7bbc" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="galactosyl-ceramide" GraphId="f0d46" Type="Metabolite">
    <Comment>Galactocerebroside</Comment>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Sphingomyelin" GraphId="f1684" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="glucosylceramide" GraphId="cf00f" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Sulfatide" GraphId="f9904" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="lactosylceramide" GraphId="f8ad4" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="GM2" GraphId="af9a2" Type="Metabolite">
    <Comment>ganglioside GM2</Comment>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="GM1a" GraphId="f409a" Type="Metabolite">
    <Comment>ganglioside GM1a</Comment>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="GA1" GraphId="d44db" Type="Metabolite">
    <Comment>ganglioside GA1</Comment>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="GM2-activator" GraphId="e3f60" Type="Protein" GroupRef="ad5af">
    <BiopaxRef>e35</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Sap-B" GraphId="c23da" Type="Protein" GroupRef="ff6aa">
        </DataNode>
  <DataNode TextLabel="GM1-beta-galactosidease (GLB)" GraphId="ae2ad" Type="Protein" GroupRef="c6ca9">
        </DataNode>
  <DataNode TextLabel="GM2-activator" GraphId="b89e9" Type="Protein" GroupRef="fa305">
        </DataNode>
  <DataNode TextLabel="Sap-B" GraphId="c8c47" Type="Protein" GroupRef="f615c">
        </DataNode>
  <DataNode TextLabel="Sap-B" GraphId="b076a" Type="Protein" GroupRef="f5915">
        </DataNode>
  <DataNode TextLabel="Sap-C" GraphId="fc596" Type="Protein" GroupRef="f5915">
        </DataNode>
  <DataNode TextLabel="Sap-C" GraphId="d24d9" Type="Protein" GroupRef="ca76d">
        </DataNode>
  <DataNode TextLabel="Sap-C" GraphId="a2834" Type="Protein" GroupRef="eca86">
        </DataNode>
  <DataNode TextLabel="glucosylceramide-beta-glucosidase" GraphId="fc8fe" Type="Protein" GroupRef="bda3b">
        </DataNode>
  <DataNode TextLabel="Sap-A" GraphId="a72cf" Type="Protein" GroupRef="bda3b">
        </DataNode>
  <DataNode TextLabel="Sap-B" GraphId="a1d6f" Type="Protein" GroupRef="dae5a">
        </DataNode>
  <DataNode TextLabel="Sap-B" GraphId="a14c7" Type="Protein" GroupRef="cffd8">
        </DataNode>
  <DataNode TextLabel="GLB1" GraphId="d813f" Type="GeneProduct" GroupRef="c6ca9">
    <Comment>GM1-beta-galactosidase 1</Comment>
        </DataNode>
  <DataNode TextLabel="HEXA" GraphId="e8365" Type="Protein" GroupRef="ad5af">
        </DataNode>
  <DataNode TextLabel="HEXB" GraphId="b8280" Type="Protein" GroupRef="bee72">
        </DataNode>
  <DataNode TextLabel="beta-hexosaminidase A, B" GraphId="ccc65" Type="Protein" GroupRef="bee72">
        </DataNode>
  <DataNode TextLabel="HEXA" GraphId="d44f6" Type="Protein" GroupRef="bee72">
        </DataNode>
  <DataNode TextLabel="GM1-beta-galactosidase (GLB)" GraphId="c2813" Type="Protein" GroupRef="f5915">
        </DataNode>
  <DataNode TextLabel="GLB1" GraphId="f6a36" Type="GeneProduct" GroupRef="f5915">
    <Comment>GM1-beta-galactosidase 1</Comment>
        </DataNode>
  <Interaction GraphId="id22df04ae">
    <Graphics>
      <Point GraphRef="c15d3"/>
      <Point GraphRef="f70d2" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id24ed80da">
    <Graphics>
      <Point GraphRef="d185f"/>
      <Point GraphRef="e9e18" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id26f37abf">
    <Graphics>
      <Point GraphRef="ca46d"/>
      <Point GraphRef="f8ad4" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4" Shape="None" GraphId="a244c"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id2a1e6503">
    <Graphics>
      <Point GraphRef="db0cb"/>
      <Point GraphRef="c50a7" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id35bb0e99">
    <Graphics>
      <Point GraphRef="c298d"/>
      <Point GraphRef="d880c" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id3e2efa63">
    <Graphics>
      <Point GraphRef="b36c8"/>
      <Point GraphRef="ce9d9" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id46549543">
    <Graphics>
      <Point GraphRef="b4cbf"/>
      <Point GraphRef="ace04" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id4bf41099">
    <Graphics LineStyle="Broken">
      <Point GraphRef="f70d2"/>
      <Point GraphRef="ad87a" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id64a389b6">
    <Graphics LineStyle="Broken">
      <Point GraphRef="fc34f"/>
      <Point GraphRef="af291" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id6688bd76">
    <Graphics LineStyle="Broken">
      <Point GraphRef="f8676"/>
      <Point GraphRef="a2976" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id7c2a3d7b">
    <Graphics LineStyle="Broken">
      <Point GraphRef="ace04"/>
      <Point GraphRef="e8292" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id8c217d78">
    <Graphics>
      <Point GraphRef="a9984"/>
      <Point GraphRef="f0d46" ArrowHead="mim-conversion"/>
      <Anchor Position="0.37605477956114364" Shape="None" GraphId="dfc65"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id90ae5278">
    <Graphics LineStyle="Broken">
      <Point GraphRef="e7fa8"/>
      <Point GraphRef="a1d81" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id98920c04">
    <Graphics LineStyle="Broken">
      <Point GraphRef="e2294"/>
      <Point GraphRef="cd557" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id9d308d67">
    <Graphics>
      <Point GraphRef="d6755"/>
      <Point GraphRef="a244c" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ida10c7dd8">
    <BiopaxRef>ae1</BiopaxRef>
    <Graphics>
      <Point GraphRef="a6bc4"/>
      <Point GraphRef="e7fa8" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ida13acca5">
    <Graphics>
      <Point GraphRef="e5944"/>
      <Point GraphRef="f8676" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ida4782145">
    <Graphics LineStyle="Broken">
      <Point GraphRef="b0526"/>
      <Point GraphRef="eaa5a" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idb3e9cfeb">
    <Graphics>
      <Point GraphRef="c6782"/>
      <Point GraphRef="d0c93" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idc05c77b0">
    <Graphics>
      <Point GraphRef="c480e"/>
      <Point GraphRef="cc3e0" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idc943199a">
    <Graphics>
      <Point GraphRef="ae054"/>
      <Point GraphRef="ca46d" ArrowHead="mim-conversion"/>
      <Anchor Position="0.44939905843435984" Shape="None" GraphId="b0526"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idd70dab2d">
    <Graphics LineStyle="Broken">
      <Point GraphRef="dfc65"/>
      <Point GraphRef="c5cf2" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="iddeefcb00">
    <BiopaxRef>c70</BiopaxRef>
    <BiopaxRef>d47</BiopaxRef>
    <Graphics LineStyle="Broken">
      <Point GraphRef="e9e18"/>
      <Point GraphRef="bd556" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ide02dbb81">
    <Graphics LineStyle="Broken">
      <Point GraphRef="d0c93"/>
      <Point GraphRef="cb3f9" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ide0d9b541">
    <Graphics>
      <Point GraphRef="d463c"/>
      <Point GraphRef="fc34f" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ide79becc4">
    <Graphics LineStyle="Broken">
      <Point GraphRef="a244c"/>
      <Point GraphRef="dcb23" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idee0b21aa">
    <Graphics LineStyle="Broken">
      <Point GraphRef="cc3e0"/>
      <Point GraphRef="af9fd" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idf3e796c4">
    <Graphics>
      <Point GraphRef="c05ac"/>
      <Point GraphRef="e2294" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idf70546d2">
    <Graphics>
      <Point GraphRef="a5d73"/>
      <Point GraphRef="b0526" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idfed1d4b4">
    <Graphics>
      <Point GraphRef="a2cca"/>
      <Point GraphRef="dfc65" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id495977f9">
    <Graphics>
      <Point GraphRef="fd574"/>
      <Point GraphRef="f8ad4" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4382080112117135" Shape="None" GraphId="d0c93"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idce1de0ee">
    <Graphics>
      <Point GraphRef="d44db"/>
      <Point GraphRef="a2bb3" ArrowHead="mim-conversion"/>
      <Anchor Position="0.5263656057099672" Shape="None" GraphId="e2294"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id66107209">
    <Graphics>
      <Point GraphRef="a2bb3"/>
      <Point GraphRef="f8ad4" ArrowHead="mim-conversion"/>
      <Anchor Position="0.44939905843435973" Shape="None" GraphId="d880c"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id763eee19">
    <Graphics>
      <Point GraphRef="e1855"/>
      <Point GraphRef="f7bbc" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4" Shape="None" GraphId="f70d2"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id151e281">
    <Graphics>
      <Point GraphRef="f8ad4"/>
      <Point GraphRef="cf00f" ArrowHead="mim-conversion"/>
      <Anchor Position="0.5541836052536739" Shape="None" GraphId="c50a7"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id829e207b">
    <Graphics>
      <Point GraphRef="f0d46"/>
      <Point GraphRef="e1855" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4293035526810647" Shape="None" GraphId="ace04"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ide4433e58">
    <Graphics>
      <Point GraphRef="cf00f"/>
      <Point GraphRef="e1855" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4" Shape="None" GraphId="fc34f"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id7db6ace7">
    <Graphics>
      <Point GraphRef="f9904"/>
      <Point GraphRef="f0d46" ArrowHead="mim-conversion"/>
      <Anchor Position="0.37802951145531316" Shape="None" GraphId="f8676"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id156a58cf">
    <Graphics>
      <Point GraphRef="f1684"/>
      <Point GraphRef="e1855" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4" Shape="None" GraphId="cc3e0"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b2908">
    <Graphics>
      <Point GraphRef="f409a"/>
      <Point GraphRef="af9a2" ArrowHead="mim-conversion"/>
      <Anchor Position="0.711849780132912" Shape="None" GraphId="e7fa8"/>
      <Anchor Position="0.4" Shape="None" GraphId="ce9d9"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b1478">
    <Graphics>
      <Point GraphRef="af9a2"/>
      <Point GraphRef="fd574" ArrowHead="mim-conversion"/>
      <Anchor Position="0.5076451892182846" Shape="None" GraphId="e9e18"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="eef6c">
    <Graphics LineStyle="Broken">
      <Point GraphRef="d880c"/>
      <Point GraphRef="af3b3" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Label TextLabel="Tay-Sachs" GraphId="c7d1d" Href="https://omim.org/272800" GroupRef="c1123">
    <Comment>DISEASE</Comment>
    <Graphics FillColor="ffcccc" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Sialidosis" GraphId="cb3f9">
    <Comment>DISEASE</Comment>
    <Graphics FillColor="ffcccc" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="GM1-gangliosidosis" GraphId="cd557" Href="https://omim.org/230500">
    <Comment>DISEASE</Comment>
    <Graphics FillColor="ffcccc" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Fabry" GraphId="dcb23" Href="https://omim.org/301500">
    <Comment>DISEASE</Comment>
    <Graphics FillColor="ffcccc" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Krabbe" GraphId="e8292" Href="https://omim.org/245200">
    <Comment>Disease</Comment>
    <Graphics FillColor="ffcccc" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Sandhoff" GraphId="eaa5a" Href="https://omim.org/268800">
    <Comment>DISEASE</Comment>
    <Graphics FillColor="ffcccc" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Sandhoff" GraphId="af3b3" Href="https://omim.org/268800">
    <Comment>DISEASE</Comment>
    <Graphics FillColor="ffcccc" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="GM1-gangliosidosis" GraphId="a1d81" Href="https://omim.org/230500">
    <Comment>DISEASE</Comment>
    <Graphics FillColor="ffcccc" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Sandhoff" GraphId="e6caa" Href="https://omim.org/268800" GroupRef="c1123">
    <Comment>DISEASE</Comment>
    <BiopaxRef>c70</BiopaxRef>
    <Graphics FillColor="ffcccc" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="GM2-gangliosidosis AB-variant" GraphId="efb5c" Href="https://omim.org/272750" GroupRef="c1123">
    <Comment>DISEASE</Comment>
    <BiopaxRef>d47</BiopaxRef>
    <Graphics FillColor="ffcccc" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Fabry" GraphId="c5cf2" Href="https://omim.org/301500">
    <Comment>DISEASE</Comment>
    <Graphics FillColor="ffcccc" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Farber" GraphId="ad87a" Href="https://omim.org/228000">
    <Comment>DISEASE</Comment>
    <Graphics FillColor="ffcccc" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Metachromatic leukodystrophy" GraphId="a2976">
    <Comment>DISEASE</Comment>
    <Graphics FillColor="ffcccc" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Gaucher" GraphId="af291" Href="https://omim.org/230800">
    <Comment>DISEASE</Comment>
    <Graphics FillColor="ffcccc" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Niemann-Pick A" GraphId="b1f83" Href="https://omim.org/257200" GroupRef="a85d4">
    <Comment>DISEASE</Comment>
    <Graphics FillColor="ffcccc" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Niemann-Pick B" GraphId="b2520" Href="https://omim.org/607616" GroupRef="a85d4">
    <Comment>DISEASE</Comment>
    <Graphics FillColor="ffcccc" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Group GroupId="dae5a" GraphId="a2cca" Style="Group"/>
  <Group GroupId="bee72" GraphId="a5d73" Style="Group"/>
  <Group GroupId="ec2eb" GraphId="a6bc4" Style="Complex"/>
  <Group GroupId="de500" GraphId="a9984" Style="Group"/>
  <Group GroupId="cbadc" GraphId="ae054" Style="Group"/>
  <Group GroupId="a85d4" GraphId="af9fd" Style="Group"/>
  <Group GroupId="b1bab" GraphId="b36c8" Style="Group"/>
  <Group GroupId="bda3b" GraphId="b4cbf" Style="Group"/>
  <Group GroupId="c1123" GraphId="bd556" Style="Group"/>
  <Group GroupId="c6ca9" GraphId="c05ac" Style="Group"/>
  <Group GroupId="eca86" GraphId="c15d3" Style="Group"/>
  <Group GroupId="fa305" GraphId="c298d" Style="Group"/>
  <Group GroupId="ff6aa" GraphId="c6782" Style="Group"/>
  <Group GroupId="ad5af" GraphId="d185f" Style="Complex"/>
  <Group GroupId="ca76d" GraphId="d463c" Style="Group"/>
  <Group GroupId="f615c" GraphId="d6755" Style="Group"/>
  <Group GroupId="f5915" GraphId="db0cb" Style="Group"/>
  <Group GroupId="cffd8" GraphId="e5944" Style="Group"/>
  <InfoBox/>
  <Biopax>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >altered sphingolipid metabolic pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >PW:0000735</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Tay-Sachs disease</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >DOID:3320</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d47">
      <bp:ID >8123671</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Classification of disorders of GM2 ganglioside hydrolysis using 3H-GM2 as substrate.</bp:TITLE>
      <bp:SOURCE >Biochim Biophys Acta</bp:SOURCE>
      <bp:YEAR >1994</bp:YEAR>
      <bp:AUTHORS >Novak A</bp:AUTHORS>
      <bp:AUTHORS >Callahan JW</bp:AUTHORS>
      <bp:AUTHORS >Lowden JA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >sphingolipid metabolic pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >PW:0000197</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Niemann-Pick disease</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >DOID:14504</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Niemann-Pick disease type A</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >DOID:0070111</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >gangliosidosis</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >DOID:2368</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="eee">
      <bp:ID >9783642403361</bp:ID>
      <bp:DB >ISBN</bp:DB>
      <bp:TITLE >Physician's Guide to the Diagnosis, Treatment, and Follow-Up of Inherited Metabolic Diseases</bp:TITLE>
      <bp:SOURCE >Springer, DOI: 10.1007/978-3-642-40337-8</bp:SOURCE>
      <bp:YEAR >2014 (ed.1)</bp:YEAR>
      <bp:AUTHORS >Blau, Nenad</bp:AUTHORS>
      <bp:AUTHORS >Duran, Marinus</bp:AUTHORS>
      <bp:AUTHORS >Gibson, K. Michael</bp:AUTHORS>
      <bp:AUTHORS >Dionisi-Vici, Carlo</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Fabry disease</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >DOID:14499</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >gangliosidosis GM2</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >DOID:3321</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Krabbe disease</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >DOID:10587</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >disease</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >DOID:4</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >glycosphingolipid metabolic pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >PW:0000733</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Tay-Sachs disease AB variant</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >DOID:4795</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >metachromatic leukodystrophy</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >DOID:10581</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c70">
      <bp:ID >9694901</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >A Pro504 --&amp;gt; Ser substitution in the beta-subunit of beta-hexosaminidase A inhibits alpha-subunit hydrolysis of GM2 ganglioside, resulting in chronic Sandhoff disease.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:AUTHORS >Hou Y</bp:AUTHORS>
      <bp:AUTHORS >McInnes B</bp:AUTHORS>
      <bp:AUTHORS >Hinek A</bp:AUTHORS>
      <bp:AUTHORS >Karpati G</bp:AUTHORS>
      <bp:AUTHORS >Mahuran D</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >sphingolipid degradation pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >PW:0000163</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Niemann-Pick disease type B</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >DOID:0070112</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >lacto-series glycosphingolipid metabolic pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >PW:0001062</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bd5">
      <bp:ID >10.1021/ja960826u</bp:ID>
      <bp:DB >DOI</bp:DB>
      <bp:TITLE >NAG-thiazoline, an N-acetylbeta-hexosaminidase inhibitor that implicates acetamido participation</bp:TITLE>
      <bp:SOURCE >J. Am. Chem. Soc.; doi:10.1021/ja960826u</bp:SOURCE>
      <bp:YEAR >1996</bp:YEAR>
      <bp:AUTHORS >Knapp S</bp:AUTHORS>
      <bp:AUTHORS >Vocadlo D</bp:AUTHORS>
      <bp:AUTHORS >Gao Z</bp:AUTHORS>
      <bp:AUTHORS >Kirk B</bp:AUTHORS>
      <bp:AUTHORS >Lou J</bp:AUTHORS>
      <bp:AUTHORS >Withers SG</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >sphingolipid biosynthetic pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >PW:0000162</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e35">
      <bp:ID >8672428</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Direct determination of the substrate specificity of the alpha-active site in heterodimeric beta-hexosaminidase A.</bp:TITLE>
      <bp:SOURCE >Biochemistry</bp:SOURCE>
      <bp:YEAR >1996</bp:YEAR>
      <bp:AUTHORS >Hou Y</bp:AUTHORS>
      <bp:AUTHORS >Tse R</bp:AUTHORS>
      <bp:AUTHORS >Mahuran DJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Sandhoff disease</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >DOID:3323</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >gangliosidosis GM1</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >DOID:3322</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Farber lipogranulomatosis</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >DOID:0050464</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Gaucher's disease</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >DOID:1926</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ae1">
      <bp:ID >9582303</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >A family of human beta3-galactosyltransferases. Characterization of four members of a UDP-galactose:beta-N-acetyl-glucosamine/beta-nacetyl-galactosamine beta-1,3-galactosyltransferase family.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:AUTHORS >Amado M</bp:AUTHORS>
      <bp:AUTHORS >Almeida R</bp:AUTHORS>
      <bp:AUTHORS >Carneiro F</bp:AUTHORS>
      <bp:AUTHORS >Levery SB</bp:AUTHORS>
      <bp:AUTHORS >Holmes EH</bp:AUTHORS>
      <bp:AUTHORS >Nomoto M</bp:AUTHORS>
      <bp:AUTHORS >Hollingsworth MA</bp:AUTHORS>
      <bp:AUTHORS >Hassan H</bp:AUTHORS>
      <bp:AUTHORS >Schwientek T</bp:AUTHORS>
      <bp:AUTHORS >Nielsen PA</bp:AUTHORS>
      <bp:AUTHORS >Bennett EP</bp:AUTHORS>
      <bp:AUTHORS >Clausen H</bp:AUTHORS>
    </bp:PublicationXref>
  </Biopax>
</Pathway>